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Introduction
Sex steroids have been used to block the synthesis and
secretion of pituitary gonadotrophins, thereby suppressing
fertility in females. Although a similar approach using
testosterone has shown some potential in males, a practical
application that does not require frequent injections of
androgen and incur the possible risk of over-stimulation of
the prostate gland has yet to be developed. Long-acting
testosterone derivatives, such as testosterone undecanoate,
have been tested as potential male antifertility agents in 
an attempt to overcome this problem (Schurmeyer and
Nieschlag, 1984; Weinbauer et al., 1986). In this regard, the
synthetic androgen 7 a -methyl-19-nortestosterone (MENT)
has been developed because of its high potency. The
anabolic effects of MENT on skeletal muscle are ten times
higher than those of testosterone (Sundaram et al., 1993). In
the same study, it was also demonstrated that the potency 
of MENT as an androgen is four times higher than that of
testosterone. However, unlike testosterone, MENT is not
5a -reduced, so that the adverse stimulatory effects on the
prostate gland are minimal (Agarwal and Monder, 1988;
Kumar et al., 1992). In addition, MENT is also 12 times
more potent than testosterone in the suppression of serum
gonadotrophin (Kumar et al., 1992). In the primate model,
MENT is ten times more potent than testosterone with
regard to the clinically desirable end points of gonado-
trophin suppression and anabolism (Cummings et al.,
1998). As oestradiol potently suppresses the hypothalamo–
pituitary axis, augmentation of the antifertility potential of
MENT was evaluated by testing the effects of chronic
administration of MENT alone or in combination with
oestradiol on the number of spermatozoa and fertility in
adult male bonnet monkeys. 
Materials and Methods
Animals 
Colony-born adult male bonnet monkeys (Macaca
radiata) of proven fertility (demonstrated by having sired at
least one offspring) and female monkeys of proven fertility
(that have given birth to at least one offspring) were selected
for the study. Adult males, weighing 6–8 kg, that showed a
clear nocturnal surge of serum testosterone were included
in this study. It was demonstrated previously that the serum
testosterone concentration in samples collected at 22:00 h
was at least threefold higher than that in samples collected
at 10:00 h. The significance of the nocturnal surge of
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Hormonal approaches to male contraception that are
based on the suppression of LH secretion require androgen
replacement treatment to maintain sexual behaviour 
and secondary sexual characteristics. Androgen supple-
mentation not only involves large and frequent doses of
testosterone esters but also results in undesirable effects on
the prostate gland. In an attempt to avoid such problems, a
synthetic androgen, 7a-methyl-19-nortestosterone (MENT),
which is much more potent than testosterone, has been
developed. In the present study, MENT was administered
at different doses (25, 50, 100, 300 and 1000 lg day–1)
either alone or in combination with oestradiol via Silastic
implants for a specified period to adult male bonnet
monkeys (Macaca radiata). Blood and semen samples were
collected at specific intervals and analysed for serum
testosterone and seminal parameters, respectively. The
results of the present study clearly indicate that adminis-
tration of MENT at all doses tested results in suppression of
the nocturnal surge of testosterone (by day 3), as well as a
decrease in the number of spermatozoa (by day 45). Co-
administration of oestradiol resulted in a reduction in the
dose of MENT required to suppress the nocturnal surge.
None of the male bonnet monkeys treated with MENT
were able to impregnate females, clearly demonstrating
the efficacy of MENT in blocking fertility in male bonnet
monkeys.
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testosterone as an index of male reproductive function, and
its dependence on LH and prolactin, has been reported by
Rao et al. (1990). All the procedures carried out on the
animals were approved by the Institutional Ethics Committee
of the Indian Institute of Science (Protocol no. 21). 
Treatment
Effect of MENT on the nocturnal surge of testosterone.
MENT was obtained from the Center for Biomedical
Research (New York). In the first set of experiments, MENT
was delivered at a known rate for 28 days using an osmotic
mini pump (model 2ML4; Alza Corporation, Palo Alto, CA)
that was implanted s.c. and changed at intervals of 28 days.
The doses of MENT administered were 100, 300 and
1000 m g day–1. The efficacy of MENT in suppressing the
hypothalamo–pituitary–gonadal axis was assessed by its
ability to inhibit the nocturnal surge of testosterone. 
LH suppression. Five adult male monkeys were castrated
bilaterally and 7 days later were implanted with mini-
osmotic pumps releasing 100 m g MENT day–1 for 14 days to
ascertain the ability of MENT to inhibit LH secretion. Blood
samples were collected on day 7 and day 14 after implan-
tation.
Effect of MENT alone or in combination with oestradiol
on fertility. As fertility trials require a long period of treat-
ment, dose responses for MENT were defined using Silastic
implants, which provided a sustained release of the steroid.
The preparation of Silastic capsules that were capable of
delivering fixed concentrations of MENT was carried out
according to the procedure described by Ewing et al.
(1983). Accordingly, an appropriate length of Silastic tubing
containing a fixed concentration of MENT was implanted to
the back of each male monkey. Different doses of MENT
were administered by varying the length of the Silastic
implants as well as the number of implants. Silastic capsules
delivering 25, 50, 100, 300 and 1000 m g MENT day–1 (n = 5
for each dose) were surgically implanted s.c. in the upper
back region of each monkey. 
Surgery
Animals were anaesthetized with ketamine hydro-
chloride (10 mg kg–1 body weight). A small incision was
made on the back of the monkey and Silastic implants
containing MENT were placed in subcutaneous tissue and
the wound was closed with silk sutures. The sutures were
removed on day 7 after surgery.
Combination of MENT and oestradiol. A lower dose of
MENT was tested in combination with oestradiol to explore
the possibility of further enhancing the antigonadotrophic
effect. A preliminary study revealed that a 1 cm Silastic
capsule containing 11 mg oestradiol is capable of main-
taining serum oestradiol concentrations at 50 pg ml–1 for
150 days; oestradiol concentrations in control monkeys
range between 5 pg ml–1 and 20 pg ml–1. On the basis of
these results, Silastic capsules capable of delivering 25 m g
MENT and a capsule of oestradiol capable of maintaining
serum oestradiol concentrations at 25 pg ml–1 were
implanted in male bonnet monkeys. In another group of
bonnet monkeys, the doses of both steroids were doubled.
The duration of the study ranged from 90 to 245 days.
During this period, blood samples were collected on
specified days at 10:00 h and 22:00 h, and serum was
separated by centrifugation at 800 g for 20 min and stored
at –208C until analysis. Semen samples were collected once
every 15 days by penile stimulation (Ramesh et al., 1998),
and the total number of spermatozoa and sperm motility
were determined under a light microscopy. Sperm motility
was scored on a scale ranging from highly motile (+++++)
to immotile (0). 
Fertility trials. Fertility trials were conducted at specified
time points between day 90 and day 180 with two groups of
animals receiving hormone treatment via Silastic implants
and the control group that received a placebo. The groups
were as follows: (i) group 1: placebo (empty capsules)
controls (n = 5); (ii) group 2: 100 m g MENT alone each day
(n = 5); (iii) group 3: 50 m g MENT each day and a Silastic
tube containing sufficient oestradiol to maintain serum
oestradiol concentrations at 50 pg ml–1 throughout the
experiment (n = 5). The fertility status of the animals was
determined by keeping male bonnet monkeys in a cage
with a female of proven fertility at days 9–14 of the
menstrual cycle. The ovulatory status of the female was
ascertained by determining serum oestradiol concentrations
on days 7, 8, 9 and 10, and serum progesterone concen-
trations on days 18–24 of the menstrual cycle. In the pri-
mate colony at the Indian Institute of Science, the menstrual
cycle is considered to be ovulatory when serum oestradiol
concentrations are at least 200 pg ml–1 between day 7 and
day 10 and serum progesterone values are at least 2 ng ml–1
between day 18 and day 24 of the menstrual cycle (Rao et
al., 1997). Each male was kept in a cage with three different
females during the fertile period of the menstrual cycle. This
procedure was performed on the basis of data showing that
a maximum of three exposures to a male of proven fertility
for three ovulatory cycles is sufficient for a female to
become pregnant (Rao et al., 1997). In addition, each
female that did not become pregnant during the three
exposures to a MENT-treated male was exposed again for
three ovulatory cycles to a control male of proven fertility to
ensure that the female monkey used in the study was fertile.
Radioimmunoassay of hormones 
Serum LH concentrations were measured by radio-
immunoassay using a macaque LH kit (generously provided
by the NICHD, Bethesda, MD). The sensitivity of the
radioimmunoassay was 0.1 ng ml–1, and the intra- and
interassay coefficients of variation were 7.5 and 9.0%,
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respectively. Iodination of LH was carried out by the
Iodogen method (Salacinski et al., 1981). The specific
activity of the 125I-labelled LH was 10–15 m ci ng–1. Serum
testosterone concentrations were measured using a
procedure described by Mukku et al. (1981). The assay had
a sensitivity of 10 pg per tube, and the intra- and interassay
coefficients of variation were 8.3 and 9.8%, respectively.
Statistical analyses 
All data are expressed as mean 6 SEM. The hormonal
concentrations and seminal parameters were analysed by
ANOVA followed by Student–Newman–Keuls’ compari-
sons to test for differences among means. Differences were
regarded as significant at P < 0.05.
Results
Effect of administration of MENT on serum LH
concentrations in castrated monkeys 
As expected, after castration, there was an increase 
in serum LH concentrations of male bonnet monkeys.
However, an increase in serum LH concentration was not
observed in castrated animals that were treated with 100 m g
MENT day–1 (Fig. 1) and this effect was observed even at
day 14 after MENT treatment, indicating that administration
of MENT results in inhibition of the hypothalamo–pituitary–
gonadal axis.
Inhibition of the nocturnal surge of serum testosterone by
MENT in intact monkeys 
Preliminary studies carried out using MENT delivered by
the osmotic pumps showed that at all doses, suppression of
the nocturnal surge of testosterone was observed by day 3,
and lower doses (25 and 50 m g) were as effective as higher
doses (P < 0.005) (Table 1). The profile of serum testos-
terone concentrations in the 100 m g dose group is presented
(Fig. 2); data from the other groups demonstrate the same
outcome and are not shown. After removal of the MENT
implants, the nocturnal testosterone surge reappeared
within 10 days. Similar results were obtained when MENT
was administered via Silastic capsules at doses of 25, 50,
100, 300 and 1000 m g per day. 
Suppression of spermatogenesis by MENT or MENT in
combination with oestradiol
Before the start of the experiment, the number of
spermatozoa of the monkeys selected for the study ranged
from 181 3 106 to 458 3 106 per ejaculate (Table 2). By
day 45, in addition to the abolition of the nocturnal surge of
serum testosterone, a sharp decrease in the number of
spermatozoa was observed, ranging from 9 3 106 to
87 3 106 per ejaculate (Table 2). A representative profile of
the number of spermatozoa in monkeys that received
100 m g MENT is presented (Fig. 3). At doses of 25–100 m g
MENT, there was a trend towards steeper and more
consistent decreases (P < 0.005) in the number of
spermatozoa compared with the higher doses such as 300
and 1000 m g. 
The data on serum testosterone concentrations are
summarized (Figs 4 and 5) and indicate that, although both
the MENT and oestradiol combination regimens were
equally effective in suppressing the nocturnal serum
testosterone surge, the suppression of the number of
spermatozoa by treatment with 50 m g MENT in
combination with 50 pg oestradiol was greater and more
prolonged (Fig. 6) than the suppression after the 25 m g
MENT and 25 pg oestradiol regimen (Fig. 7). It should also
be noted that although the number of spermatozoa
remained suppressed in monkeys treated with 50 m g MENT
in combination with 50 pg oestradiol, they tended to
increase gradually in monkeys treated with 25 m g MENT in
combination with 25 pg oestradiol (P < 0.005). Sperm
motility was significantly reduced by day 45 after MENT
administration (data not presented) and during the
subsequent period there were too few spermatozoa to
permit a reliable assessment of motility. 
Effect on fertility 
Of the several treatment regimens studied, only two
groups of animals, that is, those receiving 100 m g MENT or
50 m g MENT + 50 pg oestradiol, were subjected to fertility
testing because they showed the most consistent suppres-
sion of the number of spermatozoa.
The ovulatory nature of the menstrual cycle of the female
monkeys exposed to the treated males is shown (Table 3).
Only those cycles in which the values for serum oestradiol
concentration on any day between day 7 and day 10 of the
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Fig. 1. Effect of administration of 7a -methyl-19-nortestosterone
(MENT) (100 m g day–1) on serum LH concentrations (mean 6 SEM,
n = 5) in male bonnet monkeys (Macaca radiata). Serum LH 
was estimated by radioimmunoassay using a macaque LH kit.
*Significantly different from pre-castration value (P < 0.05),
**Significantly different from day 7 value (P < 0.05).
menstrual cycle were 200 pg ml–1 or above and serum
progesterone concentration on any day between 18 and 24
was above 2 ng ml–1 were considered ovulatory and only
such cycles were included in calculating the results. 
The results from the present study reveal that although all
the female monkeys exposed to untreated control males
became pregnant, none of the females exposed to MENT
or MENT + oestradiol-treated males became pregnant
(Table 4). A total of ten females was exposed during three
ovulatory cycles each (total of 30 cycles) to males in the
100 m g MENT-treated group. The males that received 50 m g
MENT in combination with 50 pg oestradiol were exposed
to five females during three ovulatory cycles for a total of 15
cycles. Interestingly, the females that were not impregnated
by the MENT-treated males became pregnant within three
exposures to control male monkeys, thus demonstrating 
that the females used were of normal fertility, and that the
absence of pregnancy after exposure to MENT-treated
males was not due to non-ovulatory cycles occurring at 
the time of the experiment. These results indicate that in
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Table 1. Inhibition of the nocturnal surge of testosterone in intact bonnet monkeys (Macaca radiata)
treated with 7a -methyl-19-nortestosterone (MENT)
Serum testosterone (ng ml–1)
Day 0 Day 3
Group 10:00 h 22:00 h 10:00 h 22:00 h
Control 2.63 6 0.73 19.40 6 3.82 3.98 6 0.70 23.20 6 4.55
MENT (m g)
25 5.08 6 0.46 15.83 6 2.89 2.20 6 0.40 1.58 6 0.21
50 4.70 6 0.76 20.80 6 5.40 2.33 6 0.19 1.33 6 0.29
100 3.40 6 1.40 13.10 6 2.20 2.52 6 0.25 2.24 6 0.44
300 4.42 6 1.82 12.80 6 3.16 2.99 6 0.45 3.20 6 0.40
1000 4.25 6 1.10 15.10 6 3.30 4.50 6 0.75 3.93 6 0.51
Values are mean 6 SE (n = 5 animals).
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Fig. 2. Effect of administration of 7a -methyl-19-nortestosterone (MENT) (100 m g day–1) via Silastic tubing on
serum testosterone concentrations in serum samples collected at 10:00 h (h) and at 22:00 h (j) from male
bonnet monkeys (Macaca radiata). Serum testosterone was estimated by radioimmunoassay and values
presented are mean 6 SE of five animals. 
these monkeys, suppression of the hypothalamo–pituitary–
gonadal axis with an optimal dose of MENT alone or in
combination with oestradiol at appropriate doses leads to
infertility.
Discussion
The results of the present study clearly establish that admin-
istration of MENT causes a pronounced decline in the
nocturnal surge of serum testosterone as early as day 3 after
treatment and a significant decrease in the total number of
spermatozoa at all doses of MENT tested. Although the
concept of using feedback inhibition of hypothalamo–
pituitary–gonadal axis by testosterone in males was tested
by Reddy and Rao (1972), there has been comparatively
little progress in practical application of this idea since the
feasibility study published by a consortium backed by the
World Health Organization (Anonymous, 1990). The lack
of further study has been mainly attributable to the large
dose of testosterone required to enforce azoospermia or, in
the case of a GnRH antagonist, the necessity of androgen
supplementation to maintain libido. Over the years, several
long-acting derivatives of testosterone, such as enanthate
and busiclate, have been used to supplement and suppress
spermatogenesis in the limited clinical trials. 
As several of the hormonal approaches to male contra-
ception involved androgen supplementation, there have
been attempts to synthesize potent androgen derivatives.
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Table 2. Inhibition of the nocturnal surge of testosterone and sperm count in bonnet monkeys (Macaca radiata) treated with 7a -methyl-19-
nortestosterone (MENT)
Sperm count Serum testosterone (ng ml
–1)
(106 per ejaculate) Day 0 Day 45
Group Day 0 Day 45 10:00 h 22:00 h 10:00 h 22:00 h
Control 285 6 34 258 6 17 2.63 6 0.73 19.40 6 3.82 4.25 6 0.48 17.40 6 2.29
MENT (m g)
25 181 6 6 9 6 8 5.08 6 0.46 15.83 6 2.89 1.85 6 0.44 0.78 6 0.56
50 246 6 63 21 6 9 4.70 6 0.76 20.80 6 5.40 2.10 6 0.76 0.78 6 0.26
100 224 6 20 43 6 9 3.40 6 1.40 13.10 6 2.20 3.01 6 0.53 1.54 6 0.54
300 458 6 32 85 6 26 4.42 6 1.82 12.80 6 3.16 3.05 6 0.16 2.53 6 0.33
1000 300 6 43 87 6 20 4.25 6 1.10 15.10 6 3.30 2.18 6 0.97 1.27 6 0.67
Values are mean 6 SE (n = 5 animals).
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Fig. 3. Effect of administration of 100 m g 7a -methyl-19-nortestosterone (MENT) on the number of spermatozoa in
adult male bonnet monkeys (Macaca radiata). Each value represents mean 6 SE of five monkeys. h: Control; j:
100 m g MENT.
One such compound, MENT, has been evaluated exten-
sively for its androgenic potency (Sundaram et al., 1996). It
has been demonstrated that MENT can be administered 
as a substitute for testosterone for 1 year by sub-dermal
implants. MENT does not undergo 5a -reduction and is ten
times more potent than testosterone in suppressing the
increase in the gonadotrophin concentrations after cas-
tration. In Macaca fascicularis, administration of 100 m g
MENT per day maintained prostate volume (Cummings et al.,
1998). This finding indicates that doses of this steroid that
result in gonadotrophic suppression neither hyperstimulate
the prostate gland nor detract from its normal secretory
function.
After establishing a minimum dose of MENT for effective
suppression of the nocturnal surge of testosterone, we
considered whether further inhibition of the reproductive
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Fig. 4. Effect of administration of 50 m g 7a -methyl-19-nortestosterone MENT and 50 pg oestradiol on serum
testosterone concentrations in adult male bonnet monkeys (Macaca radiata). Each value represents mean 6 SE of five
monkeys. Samples were collected at 10:00 h (h) and at 22:00 h (j).
Fig. 5. Effect of administration of 25 m g 7a -methyl-19-nortestosterone (MENT) and 25 pg oestradiol on serum
testosterone concentrations in adult male bonnet monkeys (Macaca radiata). Each value represents mean 6 SE of five
monkeys. Samples were collected at 10:00 h (h) and at 22:00 h (j).
axis could be achieved by adding a low dose of oestrogen,
because oestradiol is the most potent suppressor of LH
secretion among the sex steroids (Ewing et al., 1983).
Moreover, a recent study in humans showed that admin-
istration of oestradiol in combination with testosterone by
sub-dermal depot release augmented the gonadotrophic
suppression compared with testosterone alone (Handelsman
et al., 2000). Although the study on humans did not record a
change in the final percentage of men that achieved azoo-
spermia with oestrogen supplementation, this issue remains
open for exploration using a greater range of dosage com-
binations and with MENT as the androgen. Thus, it is hy-
pothesized that because the aromatized metabolite of MENT
is more oestrogenic than oestradiol, the aromatized meta-
bolite of testosterone, a MENT + oestradiol combination
would effectively suppress male fertility.
In the present study, the effects of administering MENT
alone or in combination with oestradiol were evaluated in
adult male bonnet monkeys. This species of monkey has
been used extensively for a variety of studies and all the
reproductive hormone profiles have been published (Rao et
al., 1997). The bonnet monkey breeds well in captivity and
under controlled breeding (that is, using animals that show
ovulatory cycles, with a fertility index of 80–85%; Rao et al.,
1997). The results of the present study clearly establish 
that administration of MENT results in suppression of the
nocturnal surge of testosterone as well as a decrease in the
number of spermatozoa. In addition, the combined dose
regimens of MENT + oestradiol were more effective than
MENT alone in suppressing the nocturnal surge of serum
testosterone and decreasing the number of spermatozoa. Of
the two combination doses tested, 50 m g MENT with 50 pg
oestradiol was more effective than 25 m g MENT + 25 pg
oestradiol at suppressing both parameters.
Administration of MENT was associated with a decrease
in testosterone concentrations observed as early as day 3 of
treatment, but the decrease in the number of spermatozoa
was observed only after day 45. It was evident that these
effects were specific to MENT as both testosterone con-
centrations and the number of spermatozoa returned to
normal within a short period after removal of the implants.
The ability of MENT to interfere with hypothalamo–pituitary–
gonadal axis was also evident from the decrease in the after
castration increase in serum LH concentrations. 
The ability of lower doses of MENT to suppress serum
testosterone concentrations and the number of spermatozoa
more effectively than the higher doses of MENT (300 and
1000 m g) could be due to the inherent androgenic effects at
the higher doses. This is also evident from the fact that none
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Fig. 6. Effect of administration of 50 m g 7 a -methyl-19-nortestosterone (MENT) plus 50 pg oestradiol on the number of
spermatozoa in adult male bonnet monkeys (Macaca radiata). Each value represents mean 6 SE of five monkeys.
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Fig. 7. Effect of administration of 25 m g 7a -methyl-19-
nortestosterone (MENT) plus 25 pg oestradiol on the number of
spermatozoa in adult male bonnet monkeys (Macaca radiata). Each
value represents mean 6 SE of five monkeys.
of the animals treated with MENT showed muscle wasting,
loss of body weight or testicular volume, which are commonly
seen when testosterone concentrations are decreased. In
fact, all of the animals gained weight during the course of
the treatment period, which provides additional evidence of
the anabolic effect of MENT. It has been reported previously
that a combination of testosterone and oestradiol is more
effective in inhibiting LH release, testicular testosterone
production and thus spermatogenesis compared with
testosterone alone (Ewing et al., 1983). It was therefore of
interest to examine whether the inclusion of oestradiol in
combination with MENT was more effective than MENT
alone. The results from the present study indicate that
inclusion of 50 pg oestradiol in combination with 50 m g
MENT was more effective than 100 m g MENT alone. This
dose of oestradiol did not cause detectable gynaecomastia
as judged by physical examination of the animals. These
results indicate that MENT in combination with oestradiol
may be potentially exploited for male contraception and 
at the same time avoids the unwanted side effects of
increased oestrogen action. Further refinement of this
potential may be realized with the advent of selective
oestrogen response modulators (Thiebaud and Secrest,
2001). It may be possible, for example, to develop a
MENT + oestradiol regimen using a selective oestrogen
response modulator in place of oestradiol, thereby potentiat-
ing the antigonadotrophic effects of the synthetic androgen
without changing, or even decreasing, the circulating
concentrations of oestradiol.
Fertility studies have clearly established the efficacy of
MENT in interfering with fertility in the treated monkeys.
None of the 15 monkeys treated with MENT was able to
impregnate females of proven fertility, and these females
did become pregnant when exposed to control males, thus
establishing that the females used for breeding studies were
of normal fertility. It is pertinent to note that in a clinical
study (Noe et al., 1999), it has been demonstrated that
administration of MENT by implants resulted in a dose-
dependent decrease in gonadotrophin and serum androgen
concentrations, without adverse reactions or changes in
clinical chemistry and haematology.
Taken together, the results of the present study indicate
that a low dose of MENT is effective in suppressing
gonadotrophins with consequent antifertility effects, with-
out resulting in adverse effects on libido or weight loss. The
effective dose of MENT may be lowered further by com-
bined administration of low-dose oestradiol.
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